| Dr Lisa Danielle Mccoy, | |
|
3043a Main Street, Glastonbury, CT 06033 | |
| (860) 657-9212 | |
| Not Available |
| Full Name | Dr Lisa Danielle Mccoy |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 3043a Main Street, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235468232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 2-010176 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Danielle Mccoy, 126 Hoyt St Apt 5b, Stamford, CT 06905-5765 Ph: (734) 395-7546 | Dr Lisa Danielle Mccoy, 3043a Main Street, Glastonbury, CT 06033 Ph: (860) 657-9212 |
News Archive
The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
With advances in genome sequencing, cancer treatments have increasingly sought to leverage the idea of "synthetic lethality," exploiting cancer-specific genetic defects to identify targets that are uniquely essential to the survival of cancer cells.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
Fibromyalgia (FM) is a debilitating condition affecting 11 million individuals in the US alone. FM carries an annual direct cost for care of more than $20 billion and drug therapies are generally only 30% effective in relieving symptoms and 20% effective in improving function. Standard care currently includes medications accompanied by exercise and coping skills approaches. In a study published in the November 2010 issue of PAIN, researchers report patients participating in a "Yoga of Awareness" program showed significantly greater improvement in FM symptoms and functioning compared to patients on a standard FM care program.
› Verified 4 days ago
Dr. Julia Karpman, DMD Dentist Medicare: Medicare Enrolled Practice Location: 416 New London Tpke, Glastonbury, CT 06033 Phone: 860-633-3671 | |
Dr. Robert W Jung, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 49 Welles St, Suite 211, Glastonbury, CT 06033 Phone: 860-633-5246 Fax: 860-633-5249 | |
Laura Borodic, DMD Dentist Medicare: Medicare Enrolled Practice Location: 379 Naubuc Ave, Glastonbury, CT 06033 Phone: 860-633-5246 | |
Dr. Reid C Risinger, DDS, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 88 Citizens Dr, Glastonbury, CT 06033 Phone: 860-633-8321 | |
Jonathan C Susat, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 416 New London Tpke, Glastonbury, CT 06033 Phone: 860-633-3671 Fax: 860-633-9128 | |
Dr. Lorin Sher, DMD, PHD Dentist Medicare: Not Enrolled in Medicare Practice Location: 49 Welles St, Suite 211, Glastonbury, CT 06033 Phone: 860-633-5246 Fax: 860-633-5249 | |
Dr. John Carroll, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 36 Welles St, Suite 240, Glastonbury, CT 06033 Phone: 860-633-2031 |